Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol plus remifentanil vs propofol plus remifentanil for bronchoscopy sedation in pulmonary tuberculosis
ChiCTR2400087524Phase 4Not yet recruiting
- Sponsor
- Yibin Second People's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pulmonary tuberculosis (TB) comparing Ciprofol + remifentanil with Propofol + remifentanil (2 arms). Primary endpoints: Coughing reaction at bronchoscope insertion, Drug induction time and 2 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
ciprofolpropofolremifentanil
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2400087524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087524.